Trademark Overview
On Wednesday, September 27, 2023, a trademark application was filed for RECLYMAZ with the United States Patent and Trademark Office. The USPTO has given the RECLYMAZ trademark a serial number of 98199156. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 4, 2024. This trademark is owned by CSL Behring L.L.C.. The RECLYMAZ trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of blood conditions; Pharmaceutical preparations for the treatment of transplant diseases, illnesses, and conditions; Pharmaceutical preparations for renal transplant diseases, illnesses, and conditions; Pharmaceutical preparations for kidney diseases, illnesses and conditions; Pharmaceutical preparations for treatment of antibody mediated rejection in adult renal transplant recipients; pharmaceutical preparations to treat hematology diseases, illnesses and conditions; Pharmaceutical preparations for the treatment of respiratory diseases, illnesses and conditions; Pharmaceutical preparations for the treatment of emphysema diseases, illnesses and conditions; Pharmaceutical preparations for the treatment of lung diseases, illnesses and conditions